Login / Signup

Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients.

Hsin-Che LinWen-Juei JengJessica LiuMei-Hung PanMei-Hsuan LeeRichard Batrla-UtermannSheng-Nan LuChuen-Fei ChenHwai-I YangChien-Jen Chen
Published in: Alimentary pharmacology & therapeutics (2024)
Patients with persistently high HBsAg levels during HBeAg-seropositive stage represent a unique population with low risk of HCC development.
Keyphrases
  • hepatitis b virus
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • prognostic factors
  • patient reported